However, this does not mean that FGF21 is not helpful for diabetes and insulin resistance in humans, and FGF21 analogs can improve the insulin signaling pathway by improving lipid metabolism and reducing lipotoxicity and chronic inflammation associated with obesity in humans. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.